AS
KYNB

Altshuler Shaham’s Kyntra Bio KYNB Stock Holding History

Altshuler Shaham’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-69
Closed -$27.6K – 413
2022
Q4 		$27.6K Buy
+69
New +$26.4K ﹤0.01% 317
2021
Q3 		– Sell
-11,803
Closed -$7.86M – 562
2021
Q2 		$7.86M Buy
+11,803
New +$6.8M 0.06% 84
2018
Q4 		– Sell
-388
Closed -$589K – 270
2018
Q3 		$589K Sell
388
-387
-50% -$596K 0.03% 99
2018
Q2 		$1.21M Buy
775
+348
+81% +$454K 0.1% 77
2018
Q1 		$494K Sell
427
-47
-10% -$61.9K 0.07% 96
2017
Q4 		$562K Buy
+474
New +$594K 0.08% 79

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Altshuler Shaham's KYNB Position: Q1 2023 in Review

Altshuler Shaham sold out of Kyntra Bio (KYNB) in Q1 2023, closing a stake of 69 shares — an estimated $27.6K sold.

Altshuler Shaham first reported a position in KYNB in Q4 2017 and held it in 6 quarters. The position peaked at $7.86M in Q2 2021. 171 funds tracked by Wall St. Rank hold KYNB as of Q1 2023.

  • Altshuler Shaham reported no remaining Kyntra Bio position as of Q1 2023 after selling out during the quarter.
  • Altshuler Shaham sold 69 Kyntra Bio shares in Q1 2023, an estimated $27.6K.
  • Altshuler Shaham first reported a position in Kyntra Bio in Q4 2017 and held it in 6 quarters.
  • Altshuler Shaham's Kyntra Bio position peaked at $7.86M in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.